
    
      The study will include an information visit, a randomization visit, a month 3 visit and a
      final visit at month 12. Besides, two visits at month 6 and 9 for dispensing of trial
      products. Outcome parameters will be measured using blood samples obtained at the
      randomization visit, the month 3 visit and at the final visit at month 12. Outcome parameters
      will moreover be analyzed based on DXA scan obtained at the randomization visit and at the
      final visit at 12 months.
    
  